EUVIMEDEUVIMED entdecken
Crossref

Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells

Chenshuang Zhang, Yilong Teng, Fengqiao Li, William Ho, Xin Bai, Xiaoyang Xu iD, Xue-Qing Zhang iD

ACS Nano · 08.08.2023 · 17 (15) · 14852-14870

DOI: 10.1021/acsnano.3c03217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 25.07.2023. Verfasst von Chenshuang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, National Key Laboratory of Innovative Immunotherapy…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai, Shanghai Jiao Tong University, Division of Chemical, Bioengineering, Environmental, and Transport Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMiceHumansAnimalsHepatic Stellate CellsInterleukin-11LiverLiver CirrhosisFibrosisInflammationRNA, Small InterferingMice, Inbred C57BL

Stichwörter der Autor:innen

IL-11 signalingactivated HSC-targeted nanoparticlesliver fibrosisnonalcoholic steatohepatitistargeted delivery of RNA-based therapeutics

Substanzen

Interleukin-11RNA, Small Interfering

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240,…

ORCID-Profile: Xiaoyang Xu, Xue-Qing Zhang

Förderung

  • Natural Science Foundation of Shanghai
  • Shanghai Jiao Tong University
  • Division of Chemical, Bioengineering, Environmental, and Transport Systems
  • Gustavus and Louise Pfeiffer Research Foundation
  • National Center of Technology Innovation for Biopharmaceuticals

Zitieren

APA

Zhang, C., Teng, Y., Li, F., Ho, W., Bai, X., Xu, X., & Zhang, X. Q. (2023). Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells. ACS Nano, 17(15), 14852-14870. https://doi.org/10.1021/acsnano.3c03217

Vancouver

Zhang C, Teng Y, Li F, Ho W, Bai X, Xu X, et al. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells. ACS Nano. 2023;17(15):14852-14870. doi:10.1021/acsnano.3c03217

BibTeX
@article{Zhang2023,
  author = {Zhang, Chenshuang and Teng, Yilong and Li, Fengqiao and Ho, William and Bai, Xin and Xu, Xiaoyang and Zhang, Xue-Qing},
  title = {Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {15},
  pages = {14852--14870},
  doi = {10.1021/acsnano.3c03217}
}
Kostenlos starten →